Dextropropoxyphene kinetics after single and repeated oral doses in man
- PMID: 4054208
- DOI: 10.1007/BF00547373
Dextropropoxyphene kinetics after single and repeated oral doses in man
Abstract
The kinetics of dextropropoxyphene (DP) and its main metabolite norpropoxyphene (NP) were studied in 6 healthy male subjects after a single oral dose of 195 mg DP HCl, and during and after 12 daily single oral doses of 195 mg DP HCl. The kinetics varied up to five-fold between individuals after the single dose, the apparent mean elimination half-life (t1/2) was 16 h for DP and 29 h for NP. The mean apparent overall plasma clearance (CL) for DP was 2.61/min. There was no systematic difference in DP clearance between the single and multiple doses, but the accuracy of individual predictions from single to multiple doses was poor, probably because of imprecise determinations of the AUC and t1/2 in the single dose experiments. The individual correlation between single and multiple dose kinetics was good for NP, although the predicted plasma levels during steady state were significantly higher than the observed levels (mean AUCss/AUCsd: 0.81). There was no sign of saturation kinetics on repeated administration. In fact, autoinduction, resulting in significantly lower plasma concentrations after treatment for 1 week was found for NP and was indicated for DP. On discontinuing DP after 12 days of treatment, the apparent mean t1/2 of DP was 23 h and of NP 25 h.
Similar articles
-
Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.Clin Pharmacol Ther. 1982 Feb;31(2):157-67. doi: 10.1038/clpt.1982.25. Clin Pharmacol Ther. 1982. PMID: 7056023
-
d-Propoxyphene kinetics after single oral and intravenous doses in man.Clin Pharmacol Ther. 1979 Oct;26(4):473-82. doi: 10.1002/cpt1979264473. Clin Pharmacol Ther. 1979. PMID: 487695
-
Pharmacokinetics of dextropropoxyphene in acute poisoning.Arch Toxicol Suppl. 1978;(1):343-6. doi: 10.1007/978-3-642-66896-8_73. Arch Toxicol Suppl. 1978. PMID: 277128
-
Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in elderly hospital patients after single and multiple doses of distalgesic. Preliminary analysis of results.Hum Toxicol. 1984 Aug;3 Suppl:41S-48S. doi: 10.1177/096032718400300105. Hum Toxicol. 1984. PMID: 6480016
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
-
Pharmacokinetics of opioids in liver disease.Clin Pharmacokinet. 1999 Jul;37(1):17-40. doi: 10.2165/00003088-199937010-00002. Clin Pharmacokinet. 1999. PMID: 10451781 Review.
-
[Sustained-release dextropropoxyphene.].Schmerz. 1991 Dec;5(4):233-42. doi: 10.1007/BF02527803. Schmerz. 1991. PMID: 18415177 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous